Related Experiment Video
Updated: Jun 11, 2026

10:10
HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
Published on: March 31, 2019
First siRNA library screening in hard-to-transfect HUVEC cells
Markus Zumbansen1, Ludger M Altrogge, Nicole Ue Spottke
1Lonza Cologne AG, Nattermannallee 1, 50829 Cologne, Germany.
Summary
This study demonstrates a new method for RNA interference (RNAi) screening in primary cells using the Nucleofector 96-well Shuttle System. This technique enables efficient small interfering RNA (siRNA) delivery for effective gene target identification in challenging cell types.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Effective target gene identification via RNA interference (RNAi) relies on biologically relevant cell types and efficient small interfering RNA (siRNA) delivery.
- Primary cells are often difficult to transfect, limiting their use in RNAi screening.
- Previous methods restricted RNAi screening to cell types amenable to lipid-mediated transfection.
Purpose of the Study:
- To evaluate the Amaxa Nucleofector 96-well Shuttle System for siRNA screening in primary cells.
- To identify genes crucial for the viability of Human Umbilical Vein Endothelial Cells (HUVECs) using siRNA libraries.
- To demonstrate the system's capability for gene target identification in previously difficult-to-transfect primary cells.
Main Methods:
- Utilized the Amaxa Nucleofector 96-well Shuttle System for transfecting primary HUVECs.
- Employed Thermo Scientific Dharmacon siGENOME siRNA Libraries targeting protein kinases and cell cycle genes.
- Screened for genes affecting cell viability, proliferation, and cell death.
Main Results:
- Identified 37 primary hits affecting HUVEC viability.
- Down-regulation of 33 genes reduced proliferation or increased cell death.
- Validated four key genes (COPB2, PYCS, CDK4, MYC) influencing HUVEC proliferation and survival.
Conclusions:
- The Nucleofector 96-well Shuttle System facilitates efficient siRNA delivery into primary cells, including those previously considered difficult to transfect.
- This technology expands the range of cell types available for RNAi-based target gene identification and validation.
- Gene target discovery can now be performed in a broader spectrum of primary cells, overcoming limitations of lipid-mediated transfection.

